BridgeBio Pharma News

BridgeBio Pharma | 8-K: Current report

Sep 11 15:33 ET

BridgeBio Pharma | 8-K: Current report

Aug 21 15:40 ET

BridgeBio Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 1 17:11 ET

BridgeBio Pharma | 8-K: BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update

Aug 1 07:36 ET

BridgeBio Pharma | 8-K: Current report

Jul 23 16:16 ET

BridgeBio Pharma | 8-K: Current report

Jun 24 16:06 ET

BridgeBio Pharma | 8-K: Current report

Jun 6 06:07 ET

BridgeBio Pharma | 8-K: BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update

May 2 07:33 ET

BridgeBio Pharma | DEFA14A: Others

Apr 25 22:17 ET

BridgeBio Pharma | DEF 14A: Definitive information statements

Apr 25 16:07 ET

BridgeBio Pharma | 8-K: Current report

Mar 6 17:16 ET

BridgeBio Pharma | 8-K: Current report

Mar 4 07:05 ET

BridgeBio Pharma | 8-K: BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update

Feb 22 07:36 ET

BridgeBio Pharma | 8-K: Current report

Jan 18 00:00 ET

BridgeBio Pharma | 8-K: Current report

Jan 8 00:00 ET

BridgeBio Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jan 5 00:00 ET

BridgeBio Pharma | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Nov 2, 2023 16:59 ET

BridgeBio Pharma | 8-K: BridgeBio Pharma Reports Third Quarter 2023 Financial Results and Business Update

Nov 2, 2023 07:31 ET

BridgeBio Pharma | 8-K: Current report

Sep 25, 2023 16:00 ET

BridgeBio Pharma | 8-K: BridgeBio Pharma Reports Second Quarter 2023 Financial Results and Business Update

Aug 3, 2023 07:32 ET